Table 2 Not-matched tumor characteristics and treatment features of female and male breast cancer patients
From: Matched-pair analysis of patients with female and male breast cancer: a comparative analysis
|  | Men |  | Women |  | χ2 |
|---|---|---|---|---|---|
Histology | Â | Â | Â | Â | Â |
DCIS | 4 | 3.7% | 3 | 2.8% | 0.14 |
Invasive ductal carcinoma | 86 | 79.6% | 64 | 59.8% | Â |
Invasive lobular carcinoma | 5 | 4.6% | 16 | 15.0% | Â |
Others* | 13 | 12.0% | 25 | 23.4% | Â |
Surgery | Â | Â | Â | Â | Â |
Mastectomy | 94 | 88.7% | 49 | 45.4% | 0.001 |
BCS | 12 | 11.3% | 51 | 47.2% | Â |
No surgery | 0 | 0% | 8 | 7.4% | Â |
Axillary dissection | 94 | 87.0% | 92 | 85.1% | 0.76 |
No axillary dissection | 14 | 13.0% | 16 | 14.8% | Â |
Adjuvant radiotherapy | Â | Â | Â | Â | Â |
Radio therapy received | 62 | 60.8% | 72 | 87.8% | 0.001 |
No therapy | 40 | 39.2% | 10 | 12, 20% | Â |
Adjuvant systemic therapy | Â | Â | Â | Â | Â |
Chemotherapy | 15 | 15% | 21 | 23.6% | 0.005 |
Chemo-/Hormone therapy | 17 | 17% | 27 | 30.3% | Â |
Hormone therapy | 31 | 31% | 31 | 34.8% | Â |
Trastuzumab | 3 | 3% | 1 | 1.1% | Â |
No therapy | 34 | 34% | 9 | 10.1% | Â |